D.A. Davidson & Co’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,235
| Closed | -$289K | – | 1186 |
|
|
2019
Q1 | $289K | Buy |
+2,235
| New | +$278K | 0.01% | 897 |
|
|
2018
Q4 | – | Sell |
-1,924
| Closed | -$267K | – | 1189 |
|
|
2018
Q3 | $267K | Buy |
1,924
+29
| +2% | +$3.64K | ﹤0.01% | 957 |
|
|
2018
Q2 | $235K | Sell |
1,895
-80
| -4% | -$9.35K | ﹤0.01% | 972 |
|
|
2018
Q1 | $220K | Hold |
1,975
| – | – | ﹤0.01% | 966 |
|
|
2017
Q4 | $236K | Sell |
1,975
-181
| -8% | -$22K | ﹤0.01% | 951 |
|
|
2017
Q3 | $302K | Buy |
2,156
+15
| +0.7% | +$2.04K | 0.01% | 848 |
|
|
2017
Q2 | $260K | Sell |
2,141
-54
| -2% | -$6.29K | 0.01% | 847 |
|
|
2017
Q1 | $266K | Sell |
2,195
-692
| -24% | -$89.2K | 0.01% | 821 |
|
|
2016
Q4 | $351K | Buy |
2,887
+1,309
| +83% | +$160K | 0.01% | 777 |
|
|
2016
Q3 | $191K | Buy |
1,578
+340
| +27% | +$43.8K | ﹤0.01% | 968 |
|
|
2016
Q2 | $143K | Buy |
1,238
+220
| +22% | +$31.2K | ﹤0.01% | 971 |
|
|
2016
Q1 | $139K | Buy |
1,018
+133
| +15% | +$19.5K | ﹤0.01% | 984 |
|
|
2015
Q4 | $167K | Hold |
885
| – | – | 0.01% | 906 |
|
|
2015
Q3 | $137K | Sell |
885
-5
| -0.6% | -$912 | ﹤0.01% | 970 |
|
|
2015
Q2 | $159K | Buy |
890
+71
| +9% | +$12.3K | 0.01% | 954 |
|
|
2015
Q1 | $140K | Sell |
819
-376
| -31% | -$68.1K | ﹤0.01% | 1004 |
|
|
2014
Q4 | $219K | Buy |
1,195
+100
| +9% | +$18.5K | 0.01% | 836 |
|
|
2014
Q3 | $180K | Buy |
1,095
+725
| +196% | +$119K | 0.01% | 903 |
|
|
2014
Q2 | $55K | Buy |
370
+295
| +393% | +$46.6K | ﹤0.01% | 1378 |
|
|
2014
Q1 | $10K | Sell |
75
-13
| -15% | -$2.07K | ﹤0.01% | 1810 |
|
|
2013
Q4 | $10K | Buy |
88
+26
| +42% | +$3.12K | ﹤0.01% | 1727 |
|
|
2013
Q3 | $6K | Buy |
62
+3
| +5% | +$329 | ﹤0.01% | 1560 |
|
|
2013
Q2 | $4K | Buy |
+59
| New | +$5.69K | ﹤0.01% | 1568 |
|
Other funds holding ALXN
BBA
